Adam D. Levy
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-15.7%
vs. S&P 500-17.4%
Beat the market0%
Paper profit on buys+$2K
Total bought / sold$15K / $2K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 6SEC | ACRVAcrivon Therapeutics, Inc. | Sell | 1,14266,008 held (−2%) | $1.57 | $2K | +21.7% |
| Jan 16SEC | ACRVAcrivon Therapeutics, Inc. | Buy | 8,83220,983 held (+73%) | $1.70 | $15K | +12.4% |
- Buy
CFO Adam D. Levy bought $15K of ACRV at $1.70 — first open-market purchase in our records; raises the stake by 73%.